Marathon Oil Corp (MRO) 11.14 $MRO Marathon Oil

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Marathon Oil Corp (MRO) 11.14 $MRO

Marathon Oil Schedules First Quarter 2016 Earnings Release and Conference Call
GlobeNewswire - Thu Mar 31, 3:20PM CDT
Marathon Oil Corporation (NYSE: MRO) announced today it plans to issue its first quarter 2016 earnings news release on Wednesday, May 4, after the close of U.S. financial markets.
MRO: 11.14 (+0.61)

29.4% Return Seen to Date on SmarTrend Marathon Oil Call (MRO)
Comtex SmarTrend(R) - Thu Mar 31, 1:41PM CDT
SmarTrend identified an Uptrend for Marathon Oil (NYSE:MRO) on March 2nd, 2016 at $8.53. In approximately 4 weeks, Marathon Oil has returned 29.39% as of today's recent price of $11.03.
MRO: 11.14 (+0.61)

Marathon Oil (MRO) Stock Gaining as Oil Prices Rise
at The Street - Thu Mar 31, 1:05PM CDT
Marathon Oil (MRO) stock is up along with the price of oil.
MRO: 11.14 (+0.61)

Look for Shares of Marathon Oil to Potentially Pullback after Yesterday's 4.75% Rise
Comtex SmarTrend(R) - Thu Mar 31, 12:09PM CDT
Marathon Oil (NYSE:MRO) traded in a range yesterday that spanned from a low of $10.42 to a high of $11.13. Yesterday, the shares gained 4.7%, which took the trading range above the 3-day high of $10.80 on volume of 12.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
MRO: 11.14 (+0.61)

Watch for Shares of Marathon Oil (MRO) to Approach Resistance at $10.91
Comtex SmarTrend(R) - Wed Mar 30, 8:35AM CDT
Marathon Oil (NYSE:MRO) has opened bullishly above the pivot of $10.21 today and has reached the first level of resistance at $10.66. Investors may be interested in a cross of the next upside pivot targets of $10.91 and $11.61.
MRO: 11.14 (+0.61)

One Reason Why Marathon Oil (MRO) Stock Closed Higher Today
at The Street - Tue Mar 29, 3:09PM CDT
Marathon Oil (MRO) stock is seen as having 'attractive remaining upside' by Deutsche Bank.
MRO: 11.14 (+0.61)


Asian stocks mostly lower following Wall Street drop
By YURI KAGEYAMA - AP - Mon Mar 28, 10:26PM CDT
TOKYO (AP) — Asian stocks mostly slipped in narrow trading Tuesday following a drop on Wall Street disappointed by U.S. economic data.
P: 8.95 (-0.55), MRO: 11.14 (+0.61), TWX: 72.55 (+0.39)

Marathon Oil (MRO) Stock Down as Oil Prices Slip
at The Street - Mon Mar 28, 3:02PM CDT
Marathon Oil (MRO) stock fell on Monday due to the dip in oil prices.
MRO: 11.14 (+0.61)

Week Ahead: Energy Sector's Debt Bomb Ready to Explode
at The Street - Sun Mar 27, 1:02PM CDT
We spotlight the energy and bank stocks to watch in the week ahead, as their distressed balance sheets come to the fore amid a renewed decline in oil prices.
C: 41.75 (-0.13), COP: 40.27 (+0.19), BAC: 13.52 (+0.04), SDRL: 3.30 (+0.02), PBR: 5.84 (-0.02), JPM: 59.22 (-0.49), RIG: 9.14 (+0.25), CHK: 4.12 (+0.11), LINE: 0.36 (-0.02), MRO: 11.14 (+0.61), BHI: 43.83 (+0.46), APC: 46.57 (+0.18), XLE: 61.89 (-0.03)

Energy Stocks Take a Breather This Week (MRO, CRC, DNR, LPG, BRS)
Matthew DiLallo, The Motley Fool - Motley Fool - Sat Mar 26, 9:45AM CDT
Image Source: Marathon Oil After a meteoric rise from the mid-$20s to more than $40 a barrel, crude took a breather this week, ending down 4%, and below $40 a barrel. That took energy stocks down with it, with dozens dropping double digits this...
CRC: 1.03 (-0.02), BRS: 18.92 (-0.05), LPG: 9.40 (+0.32), MRO: 11.14 (+0.61), DNR: 2.22 (+0.05)

NY comptroller: 5 companies to disclose political spending
By MICHAEL VIRTANEN - AP - Fri Mar 25, 10:46AM CDT
ALBANY, N.Y. (AP) — Five more Fortune 500 companies have agreed to publicly report all direct and indirect political spending, according to New York's comptroller.
RAI: 50.31 (-0.17), NBL: 31.41 (+0.63), HOG: 51.33 (+1.85), KR: 38.25 (+0.16), PCG: 59.72 (+0.28), WU: 19.29 (-0.04), PCL: 36.54 (-1.53), CMCSK: 58.00 (-1.69), MAR: 71.18 (-0.37), SRE: 104.05 (+0.58), CSX: 25.75 (-0.55), AET: 112.35 (-1.84), LUV: 44.80 (-0.18), PEP: 102.48 (-0.21), JNJ: 108.20 (-0.78), VLO: 64.14 (+0.16), ESRX: 68.69 (-0.36), NI: 23.56 (+0.17), MRO: 11.14 (+0.61), X: 16.05 (-0.41), CMCSA: 61.08 (+0.28), UNP: 79.55 (-1.01), TRV: 116.71 (-0.72)

Marathon Oil (MRO) Stock Climbs, Oil Pares Losses on Baker Hughes Data
at The Street - Thu Mar 24, 1:48PM CDT
Marathon Oil (MRO) shares are advancing on Thursday as oil futures shook off earlier losses following the Baker Hughes (BHI) report.
MRO: 11.14 (+0.61)

10 Women Who Would Be a Great Addition to Any Company's Board
at The Street - Thu Mar 24, 12:03PM CDT
Seven companies in the S&P 500 have no women on their boards. Maybe they're having trouble finding the right women? We aren't. Here are 10 that would make great additions.
CXO: 101.04 (-0.91), HST: 16.70 (+0.24), MDLZ: 40.12 (-0.34), HON: 112.05 (-0.12), CAH: 81.95 (+0.17), KORS: 56.96 (+0.09), IDA: 74.59 (-0.06), DO: 21.73 (+0.35), AMAT: 21.18 (+0.14), EOG: 72.58 (-1.08), MSFT: 55.23 (+0.18), REV: 36.41 (+0.53), MU: 10.47 (-0.01), HAR: 89.04 (+2.03), SWKS: 77.90 (+0.05), PFE: 29.64 (-0.43), MCHP: 48.20 (-0.64), LLTC: 44.56 (-0.22), UL: 45.18 (-0.59), MGM: 21.44 (+0.15), CELG: 100.09 (+1.29), GILD: 91.86 (-0.11), TXN: 57.42 (-0.95), MRK: 52.91 (-0.31), QLGC: 13.44 (+0.06), ADI: 59.19 (+0.08), MRO: 11.14 (+0.61), CVX: 95.40 (+0.15), XRAY: 61.63 (-0.43), NVS: 72.44 (-0.11), GRMN: 39.96 (+0.10), CCE: 50.74 (-0.35), K: 76.55 (-0.28), JNPR: 25.51 (unch), IBM: 151.45 (+3.04), APA: 48.81 (+0.17), GOOGL: 762.90 (-5.44), TER: 21.59 (+0.03), ALGN: 72.69 (+0.68), MET: 43.94 (-0.79), DISCA: 28.63 (+0.54), FCAU: 8.06 (-0.09), ISIL: 13.37 (+0.02), ORCL: 40.91 (-0.06), SQ: 15.28 (+0.26), GS: 156.98 (+0.48), QRVO: 50.41 (-0.82), LRCX: 82.60 (+0.41), BAX: 41.08 (-0.18), GM: 31.43 (+0.44), CRUS: 36.41 (+0.08), PG: 82.31 (-0.37), AVGO: 154.50 (-2.43), GSBD: 19.60 (+0.07), CRM: 73.83 (-0.47)


Asian markets fall for 2nd day after oil decline
By JOE McDONALD - AP - Wed Mar 23, 10:40PM CDT
BEIJING (AP) — Asian stock markets fell for a second day Thursday after declines in prices of oil and other commodities pulled Wall Street lower.
MRK: 52.91 (-0.31), MRO: 11.14 (+0.61)

Watch for Marathon Oil to Potentially Rebound After Falling 6.81% Yesterday
Comtex SmarTrend(R) - Wed Mar 23, 1:26PM CDT
Marathon Oil (NYSE:MRO) traded in a range yesterday that spanned from a low of $10.41 to a high of $11.23. Yesterday, the shares fell 6.8%, which took the trading range below the 3-day low of $11.20 on volume of 14.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
MRO: 11.14 (+0.61)

Marathon Oil (MRO) Stock Drops, Oil Prices Sink on EIA Data
at The Street - Wed Mar 23, 11:57AM CDT
Marathon Oil (MRO) stock is retreating in midday trading on Wednesday as oil prices drop on new EIA data.
MRO: 11.14 (+0.61)

Marathon Oil (MRO) Breaks Through Support at $11.18
Comtex SmarTrend(R) - Wed Mar 23, 8:35AM CDT
Shares of Marathon Oil (NYSE:MRO) opened today below their pivot of $11.38 and have already reached the first level of support at $11.18. Analysts will be watching for a cross of the next downside pivot targets of $11.05 and $10.73.
MRO: 11.14 (+0.61)

Marathon Oil (MRO) Stock Down on Mixed Oil Prices
at The Street - Tue Mar 22, 2:24PM CDT
Marathon Oil (MRO) stock is decreasing on Tuesday afternoon as oil prices trimmed earlier losses, but remained mixed.
MRO: 11.14 (+0.61)

Marathon Oil Up 32.9% Since SmarTrend Uptrend Call (MRO)
Comtex SmarTrend(R) - Tue Mar 22, 1:13PM CDT
SmarTrend identified an Uptrend for Marathon Oil (NYSE:MRO) on March 2nd, 2016 at $8.53. In approximately 3 weeks, Marathon Oil has returned 32.90% as of today's recent price of $11.33.
MRO: 11.14 (+0.61)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 4

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
PANDAG G1 Debuts: Revolutionizing Lawn Care Efficiency

Updated Category News Views 4

The Future of Landscaping Unveiled Get this—PANDAG is set to shake things up at GaLaBau 2026 with their futuristic G1 autonomous mower. This isn't just another piece of lawn equipment; it's practically a tech marvel on wheels, weaving together LiDAR, AI Vision, RTK, and 4G tech to make it the ultimate multitasker for the landscaping industry. We're talking obstacle...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 6

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
GORGIE Unleashes Berry Burst: Target's New Drink Star

Updated Category News Views 5

GORGIE Targets Taste Buds with Berry Burst Ever feel like you're missing out on that energy drink everyone seems to be raving about? Well, GORGIE's out there making some noise again, and this time it's got a new punchy player in the game: Berry Burst. It's not just another drink; it's shaking things up in the energy aisle with its exclusive launch at Target. Modern style...

Continue Reading
Ris-Rez May Set New Standard in Relapsed SCLC

Updated Category News Views 6

The Game-Changing Results Innovation in pharmaceuticals sometimes feels like a waiting game, but when a fresh breakthrough like this rolls in, it lights up the whole landscape. Risvutatug rezetecan, or Ris-Rez for short, has shown promising potential in the fight against relapsed small-cell lung cancer (SCLC) that has progressed after platinum-based therapy. Survival...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 2

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
UWM Faces Class Action Deadline: Key Insights for Investors

Updated Category News Views 2

The High Stakes Reality for UWM Investors If there's one thing that's certain in this jittery world of investing, it's that losses have a way of waking you up. Right now, anyone tied up with UWM Holdings Corporation (NYSE: UWMC) shares needs to keep their wits about them; we're barreling toward an October 13, 2026 deadline for a class action lawsuit. The clock's ticking...

Continue Reading
Surfing Dogs Ride Waves, Support Orphan Pets

Updated Category News Views 2

Waves, Paws, and Passion Who would've thought that dogs catching waves could also catch hearts and wallets? Well, that's exactly what's happening today at Del Mar Dog Beach with the 21st Annual Surf Dog Surf-A-Thon revving up the excitement. It's a sun-soaked day in Rancho Santa Fe, California, right in the thick of things at the longest-running dog surf competition. For...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 7

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 5

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading

Top 5 Most Recently Viewed Articles

Exro Technologies Reveals Quarterly Progress and Financial Insights

Updated Category News Views 362

Exro Technologies Reports First Quarter Results Exro Technologies Inc. (TSX: EXRO), a prominent tech company specializing in power control solutions for electric vehicles and energy storage, has recently announced its financial results for the first quarter of the year. This highlights their ongoing transition from technology validation towards commercial operations and...

Continue Reading
dsm-firmenich Appoints New Leaders to Propel Future Growth

Updated Category News Views 548

dsm-firmenich Welcomes New Executive Committee Members dsm-firmenich is set to usher in a transformative era by strengthening its Executive Committee, as it embarks on a journey to intensify its consumer-centered approach. This restructuring aims to solidify its standing as a top-tier partner in creation and innovation across the nutrition, health, and beauty sectors. The...

Continue Reading
Insight Partners Rolls Out $12.5B for Software Innovation Growth

Updated Category News Views 805

Insight Partners Launches New Funds to Propel Software Innovation Global software investor, Insight Partners, has recently celebrated a significant milestone by announcing the closing of its thirteenth flagship fund alongside a dedicated buyout co-invest fund, collectively known as "Fund XIII". This announcement is particularly special as it coincides with the firm's 30th...

Continue Reading
Acumatica's AI Innovations Transform Business Operations

Updated Category News Views 123

Acumatica's AI Innovations Transform Business Operations During an inspiring keynote at a recent summit, Acumatica showcased its commitment to revolutionizing business operations with an AI-first product strategy. This innovative approach aims to significantly enhance how small and mid-sized businesses operate, addressing the real-world challenges they face. With advanced...

Continue Reading
Microbiological Testing of Water Market Growth Forecasts

Updated Category News Views 101

The Expanding Microbiological Testing of Water Market As the demand for clean and safe water continues to surge, the global microbiological testing of water market is set to experience significant growth, reaching an impressive $2.3 billion by 2027, with a robust compound annual growth rate (CAGR) of 7.4%. The rising consciousness among consumers regarding the importance...

Continue Reading